Literature DB >> 7876653

Discussion: who should receive hepatitis A vaccine? A strategy for controlling hepatitis A in the United States.

F B Hollinger1, T Eickhoff, A Gershon, E C Jong, R S Koff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876653     DOI: 10.1093/infdis/171.supplement_1.s73

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Seroepidemiology of hepatitis A in Delhi.

Authors:  A K Dutta; A Aggarwal; A K Kapoor; G N Ray; S Batra
Journal:  Indian J Pediatr       Date:  2000-02       Impact factor: 1.967

2.  Projections of hepatitis A virus infection associated with flood events by 2020 and 2030 in Anhui Province, China.

Authors:  Lu Gao; Ying Zhang; Guoyong Ding; Qiyong Liu; Changke Wang; Baofa Jiang
Journal:  Int J Biometeorol       Date:  2016-05-12       Impact factor: 3.787

3.  Anti-hepatitis A seroprevalence among chronic viral hepatitis patients in Kelantan, Malaysia.

Authors:  Fazlina Ahmad; Nor Aizal Che Hamzah; Nazri Mustaffa; Siew Hua Gan
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

4.  Seroprevalence of viral hepatitis A in the Czech Republic.

Authors:  J Beran; P Douda; R Rychlý
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

Review 5.  Enteric hepatitis viruses.

Authors:  Seyed Mohammad Ebrahim Tahaei; Seyed Reza Mohebbi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.